Watson acquires CoCensys sales division, copromotion rights to Somerset Eldepryl, Warner-Lambert Zarontin.
Executive Summary
WATSON TO COPROMOTE SOMERSET ELDEPRYL, WARNER-LAMBERT ZARONTIN as part of Watson's agreement to acquire CoCensys' sales and marketing division for $9 mil. in cash. Watson will take over approximately 70 CoCensys U.S. sales personnel through the transaction. CoCensys received $6 mil. on closing, with the balance to be paid upon the occurrence of certain future events.
You may also be interested in...
Purdue Boosts Early-Stage Neuroscience Research With CoCensys Buy
Purdue Pharma is boosting its early-stage research with the purchase of the neuroscience firm CoCensys for a total cash price of $9.5 mil.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011